ILC Therapeutics

Medical Incubator Japan targets further UK healthcare investments in 2021

Medical Incubator Japan (MIJ), an independent venture capital fund investing in early-stage life sciences companies, is planning further UK healthcare investments in 2021 after completing two landmark UK investments in 2020.

Published 3 March 2021

ILC Therapeutics announces first international investor

Lanarkshire-based biotechnology company ILC Therapeutics (ILCT) has announced that it has secured significant investment from its first global investor Medical Incubator Japan (MIJ).

Published 1 December 2020